Greg Mohl

In this interview, Greg Mohl, PhD highlights the challenges of delivering CRISPR therapies to the brain and discusses how him and the research team try to balance designing the most effective therapy with the time pressure to get therapies to patients.

Dr. Mohl is a Postdoctoral Scholar at the University of California, San Francisco. He is part of the SCGE project titled “Correction of Neurological Disease via Allele Specific Excision of Pathogenic Repeats”.